Herein, we report a silver‐catalyzed [5+2] cycloaddition of terminal alkynes with imidazolidines, enabling the efficient synthesis of 1,4‐diazepines under mild conditions. The imidazolidine substrate acts as a novel 5‐atom synthon, undergoing silver‐mediated cyclization with terminal alkynes to deliver diverse 1,4‐diazepines in up to 92% yield with excellent functional group tolerance. This method provides a convenient route to access the privileged seven‐membered diazacyclic core, which is widely found in pharmaceuticals and bioactive molecules. Notably, the catalytic system is also applicable to the formal [6+2] cycloaddition of terminal alkynes with hexahydropyrimidines, allowing the construction of synthetically challenging eight‐membered diazacycles.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: